Literature DB >> 28273205

Expression of E-cadherin and involucrin in leukoplakia and oral cancer: an immunocytochemical and immunohistochemical study.

Alessandra Dutra da Silva1, Bruna Jalfim Maraschin2, Natalia Koerich Laureano2, Natália Daroit2, Fernanda Brochier2, Leonardo Bündrich2, Fernanda Visioli2, Pantelis Varvaki Rados2.   

Abstract

To assess the immunocytochemical and immunohistochemical correlation of adhesion (E-cadherin) and cell differentiation (involucrin) molecules in oral leukoplakia and oral squamous cell carcinoma. Cytological samples and biopsies were obtained from male and female patients aged over 30 years with oral leukoplakia (n = 30) and oral squamous cell carcinoma (n = 22). Cell scrapings and the biopsy were performed at the site of the lesion and histological slides were prepared for the immunocytochemical analysis of exfoliated oral mucosal cells and for the immunohistochemical analysis of biopsy tissues using E-cadherin and involucrin. Spearman's correlation and kappa coefficients were used to assess the correlation and level of agreement between the techniques. Immunostaining for E-cadherin and involucrin by both techniques was similar in the superficial layers of the histological sections compared with cell scrapings. However, there was no statistical correlation and agreement regarding the immunocytochemical and immunohistochemical expression of E-cadherin and involucrin in oral leukoplakia (R = 0.01, p = 0.958) (Kappa = 0.017, p = 0.92) or in oral squamous cell carcinoma (R = 0.26, p = 0.206) (Kappa = 0.36, p = 0.07). The immunoexpression of E-cadherin and involucrin in tissues is consistent with the expression patterns observed in exfoliated oral mucosal cells, despite the lack of a statistically significant correlation. There is an association of the histopathological characteristics of leukoplakia with the expression E-cadherin and of the microscopic aspects of oral squamous cell carcinoma with immunohistochemical expression of involucrin.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28273205     DOI: 10.1590/1807-3107BOR-2017.vol31.0019

Source DB:  PubMed          Journal:  Braz Oral Res        ISSN: 1806-8324


  5 in total

1.  PTHLH Predicts the Prognosis of Patients with Oral Leukoplakia.

Authors:  Zhongjing Lv; Rong Cong; Jiafeng Li; Kun Cao; Qiang Bao; Linlin Li; Feng Yang; Jian Yuan
Journal:  Onco Targets Ther       Date:  2020-10-08       Impact factor: 4.147

2.  Coalition of E-cadherin and vascular endothelial growth factor expression in predicting malignant transformation in common oral potentially malignant disorders.

Authors:  P Sharada; Uma Swaminathan; B R Nagamalini; K Vinod Kumar; B K Ashwini; Vln Lavanya
Journal:  J Oral Maxillofac Pathol       Date:  2018 Jan-Apr

3.  Expression of E- Cadherin and Levels of Dysplasia in Oral Leukoplakia - A Prospective Cohort Study.

Authors:  I Ilangani Sathish; Kannan Asokan; Krithika C L; Arvind Ramanathan
Journal:  Asian Pac J Cancer Prev       Date:  2020-02-01

4.  Co-expression network-based identification of biomarkers correlated with the lymph node metastasis of patients with head and neck squamous cell carcinoma.

Authors:  Yu Jin; Xing Qin
Journal:  Biosci Rep       Date:  2020-02-28       Impact factor: 3.840

Review 5.  A Systematic Review of Oral Biopsies, Sample Types, and Detection Techniques Applied in Relation to Oral Cancer Detection.

Authors:  Guanghuan Yang; Luqi Wei; Benjamin K S Thong; Yuanyuan Fu; Io Hong Cheong; Zisis Kozlakidis; Xue Li; Hui Wang; Xiaoguang Li
Journal:  BioTech (Basel)       Date:  2022-03-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.